Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Barrett Esophagus-II: Clinical Manifestations and Management
Gastroesophageal Reflux Disease II: Clinical Features and Management
Antiasthma Drugs: Leukotriene Modifiers
Peptic Ulcer Disease IV: Management
Esophageal Strictures-II: Clinical Features and Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 9, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Javier Molina-Infante1,2, Alfredo J Lucendo2,3,4
1Servicio de Aparato Digestivo, Hospital Universitario de Cáceres, Cáceres, España. Servicio de Aparato Digestivo Hospital Universitario de Cáceres Cáceres España.
Eosinophilic esophagitis (EoE), an allergic disorder, is increasingly prevalent. Recent advances include targeted therapies like novel corticosteroids and biologics, alongside dietary and endoscopic interventions, improving patient outcomes.
Area of Science: